β-Amyloid activates the mitogen-activated protein kinase cascade via hippocampal α7 nicotinic acetylcholine receptors: In Vitro and in Vivo mechanisms related to Alzheimer's disease

Journal of Neuroscience

Volumn 21, Issue 12, 2001, Pages 4125-4133

  Dineley, K T ^a   Westerman, M ^a   Bui, D ^a   Bell, K ^a   Ashe, K H ^a   Sweatt, J D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyloid; Hippocampus; Kinase; Learning; MAPK; Memory; Nicotinic receptor

Indexed keywords

AMYLOID BETA PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINIC RECEPTOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN TISSUE; CONTROLLED STUDY; ENZYME ACTIVATION; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; MEMORY; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; SENILE PLAQUE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0035875962     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-12-04125.2001     Document Type: Article

References (62)

1. Cerebrospinal fluid β-amyloid (1-42) in Alzheimer disease: Differences between early-and late-onset Alzheimer disease and stability during the course of disease
2. Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment
3. Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease
4. The MAPK cascade is required for mammalian associative learning
5. A mitogen-activated protein kinase cascade in the CA1/CA2 subfield of the dorsal hippocampus is essential for long-term spatial memory
6. Inherited neurodegenerative diseases and transgenic models
7. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element binding protein
8. 125I]-α-bungarotoxin binding in human postmortem brain
9. Predicting the in vitro toxicity of synthetic β-amyloid (1-40)
10. Assembly and aggregation properties of synthetic Alzheimer's α4/β-amyloid peptide analogs
11. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
12. Image analysis of β-amyloid load in Alzheimer's disease and relation to dementia severity
13. β-Amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease
14. The MAPK/ERK cascade targets both Elk-1 and cAMP response element-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus in vivo
15. The β-amyloid precursor protein and its derivatives: From biology to learning and memory processes
16. Activation of the L voltage-sensitive calcium channel by mitogen-activated protein (MAP) kinase following exposure of neuronal cells to β-amyloid. MAP kinase mediates β-amyloid-induced neurodegeneration
17. A requirement for the mitogen-activated protein kinase cascade in hippocampal long-term potentiation
18. Upregulation of surface α4β2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine
19. Similar levels of long-term potentiation in amyloid precursor protein: Null and wild-type mice in the CA1 region of picrotoxin-treated slices
20. Acetylcholine activates an α-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells
21. Evidence for modulation of GABAergic neurotransmission by nicotine
22. Nicotine interferes with GABA-mediated inhibitory processes in mouse hippocampus
23. Soluble amyloid Aβ (1-40) exists as a stable dimer at low concentrations
24. Protofibrillar intermediates of amyloid-β protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons
25. Transgenic mice expressing Alzheimer amyloid precursor proteins
26. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice
27. 2+ stimulation of CREB-dependent transcription and ERK nuclear translocation
28. APPSw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1
29. Aβ deposition is associated with neuropil changes, but not with overt neuronal loss, in the human amyloid precursor protein V717F (PDAPP) transgenic mouse
30. Nicotinic receptor stimulation protects neurons against β-amyloid toxicity
31. Cellular signaling pathways and cytoskeletal organization
32. Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains
33. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins
34. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors
35. Nicotinic receptor activation excites distinct subtypes of interneurons in the rat hippocampus
36. Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathway
37. Amyloid-β protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease
38. Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline
39. PET studies and cholinergic therapy in Alzheimer's disease
40. Mice homozygous for the L250T mutation in the α7 nicotinic acetylcholine receptor show increased neuronal apoptosis and die within 1 day of birth
41. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase)
42. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia, and Alzheimer's disease: Possible index of early neuropathology
43. β-Amyloid 1-42 peptide directly modulates nicotinic receptors in the rat hippocampal slice
44. PD98059 prevents neurite degeneration induced by fibrillar β-amyloid in mature hippocampal neurons
45. Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor
46. Transient activation of cyclic AMP-dependent protein kinase during hippocampal long-term potentiation
47. The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus
48. Hyperactivation of signal transduction systems in Alzheimer's disease
49. Memory consolidation for contextual and auditory fear conditioning is dependent on protein synthesis, PKA, and MAP kinase
50. 18F]fluoro-A-85380: An in vivo tracer for the nicotinic acetylcholine receptor
51. Molecular cloning, functional properties, and distribution of rat brain α7: A nicotinic cation channel highly permeable to calcium
52. A necessity for MAP kinase activation in mammalian spatial learning
53. The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease
54. A simple method for organotypic cultures of nervous tissue
55. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II
56. Three-year follow-up of cerebrospinal fluid tau, β-amyloid 42 and 40 concentrations in Alzheimer's disease
57. β-Amyloid (1-42) binds to α7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology
58. Coactivation of β-adrenergic and cholinergic receptors enhances the induction of long-term potentiation and synergistically activates mitogen-activated protein kinase in the hippocampal CA1 region
59. ERK plays a regulatory role in induction of LTP by theta frequency stimulation and its modulation by β-adrenergic receptors
60. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase
61. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
62. Enhanced synaptic potentiation in transgenic mice expressing presenilin 1 familial Alzheimer's disease mutation is normalized with a benzodiazepine